SKYEY - SkyePharma PLC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SKYEY - SkyePharma PLC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote ()	3/13/2000 10:51:00 AM
From: sim1	of 56

SkyePharma Signs Contract with Pfizer LONDON, March 13 /PRNewswire/ -- SkyePharma PLC (Nasdaq: SKYE - news; London: SKP) announced today that it had signed a Feasibility Contract with Pfizer Limited. Commercial details of the relationship are confidential. However, SkyePharma confirmed that it is using its advanced oral GEOMATRIX delivery technology to formulate a Pfizer compound. SkyePharma's GEOMATRIX delivery systems are based on an advanced family of tablet technologies which control the amount, timing and location of release of a drug. Michael Ashton, Chief Executive Officer of SkyePharma said: "We are delighted to announce that Pfizer has joined our list of clients. SkyePharma believes that GEOMATRIX has substantial advantages over competitor delivery technologies." <snip>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next